JD.com Inc. ADR buy Subdi
Start price
27.12.18
/
50%
€18.91
Target price
22.10.24
€88.00
Performance (%)
15.52%
End price
27.02.24
€21.85
Summary
This prediction ended on 27.02.24 with a price of €21.85. The BUY prediction by Subdi finished with a performance of 15.52%. A total of €1.76 was paid as dividends for this prediction. Subdi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| JD.com Inc. ADR | 6.054% | 6.054% | -21.726% | -59.874% |
| iShares Core DAX® | 0.160% | -1.640% | 12.016% | 15.557% |
| iShares Nasdaq 100 | -3.020% | -4.715% | 37.102% | 42.685% |
| iShares Nikkei 225® | -2.519% | -7.621% | 18.066% | 2.904% |
| iShares S&P 500 | -1.377% | -2.809% | 26.536% | 41.689% |
Comments by Subdi for this prediction
In the thread JD.com Inc. ADR diskutieren
Wiederaufnahme
Subdi stimmt am 27.12.2018 der Buy-Einschätzung von Subdi mit dem Kursziel 42,5$ zu.
Überschrift: Subdi stimmt der Buy-Einschätzung von Maxi-Scalibusa zu
JD.com profitiert von der Corona-Virus-Situation, denn die Leute kaufen angesichts der Mundschutz Pflicht und der Ausgangssperren lieber online ein. Der Kursverlust ist unlogisch, und eine Kaufgelegenheit!
JD.Com: Prospering In Difficult Times
Feb. 27, 2020 5:04 AM ET|16 comments | About: JD.com, Inc. (JD)
From Growth to Value Potential Multibaggers helps you find multibaggers early on.
Summary
- By doing the right thing and communicating about this, JD picks up a huge amount of goodwill from the Chinese people.
- Online orders of food, drugs, entertainment technology, and fitness accessories all are exploding. This article gives you the numbers.
- JD Health has opened up its telehealth services for free, 24/7. That will lower the threshold a lot for many people after Covid-19 has been pushed back.
- JD's sales have been boosted by Covid-19 and the longer the crisis lasts, the better JD will do over the long term.
JD.com Q4 2019 Earnings Preview
- JD.com (NASDAQ:JD) is scheduled to announce Q4 earnings results on Monday, March 2nd, before market open.
- The consensus EPS Estimate is $0.06 (-14.3% Y/Y) and the consensus Revenue Estimate is $23.8B (+21.4% Y/Y).
- Over the last 2 years, JD has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 5 downward.
- Revenue estimates have seen 4 upward revisions and 1 downward.
- Now read: JD.Com: Prospering In Difficult Times »
JD.com jumps 8% on Q4 earnings beat
- JD.com (NASDAQ:JD): Q4 Non-GAAP EPS of $0.08 beats by $0.02; GAAP EPS of $0.35 beats by $0.40.
- Revenue of $24.5B (+26.6% Y/Y) beats by $700M.Shares +8.3% PM.
- Press Release
Kursziel geändert auf 53,0
Kursziel geändert auf 58,0
Kursziel geändert auf 68,0
Kursziel geändert auf 88,0
Ein wichtiges Signal für den Aktienkurs? ... South China Morning Post: